BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 812671)

  • 1. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
    Pool D; Bloom W; Mielke DH; Roniger JJ; Gallant DM
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):99-104. PubMed ID: 812671
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
    Paprocki J; Versiani M
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
    Wittkopp TA
    J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
    Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
    Moyano CZ
    Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
    Moore DF
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):172-80. PubMed ID: 809232
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled double-blind comparison between loxapine and haloperidol in acute newly hospitalized schizophrenic patients.
    Paprocki J; Barcala Peixoto MP; Andrade NM
    Psychopharmacol Bull; 1976 Apr; 12(2):32-4. PubMed ID: 769026
    [No Abstract]   [Full Text] [Related]  

  • 9. Loxapine succinate in the treatment of newly admitted schizophrenic patients.
    Chouinard G; Annable L; DeMontigny C; Kropsky ML
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):73-9. PubMed ID: 12921
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loxapine concentrate in acute schizophrenia.
    O'Connell RA; Jeewa M; Allen K
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
    [No Abstract]   [Full Text] [Related]  

  • 12. Loxapine (Loxitane).
    Med Lett Drugs Ther; 1975 Dec; 17(25):103. PubMed ID: 1105124
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia.
    Clark ML; Paredes A; Costiloe JP; Fulkerson FG; Wood F
    Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.
    Petrie WM; Ban TA; Berney S; Fujimori M; Guy W; Ragheb M; Wilson WH; Schaffer JD
    J Clin Psychopharmacol; 1982 Apr; 2(2):122-6. PubMed ID: 7042770
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of loxapine succinate in acute schizophrenia: a comparative study with thiothixene.
    van der Velde CD; Kiltie H
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):1-12. PubMed ID: 806422
    [No Abstract]   [Full Text] [Related]  

  • 16. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 17. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
    Schiele BC
    Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral loxapine in severely disturbed schizophrenic patients.
    Deniker P; Loo H; Cottereau MJ
    J Clin Psychiatry; 1980 Jan; 41(1):23-6. PubMed ID: 6101324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
    Tuason VB; Escobar JI; Garvey M; Schiele B
    J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
    Mattke DJ; Mombour W; Glötzner FL
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):36-44. PubMed ID: 788001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.